Found: 6
Select item for more details and to access through your institution.
One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration.
- Published in:
- Bioengineering (Basel), 2023, v. 10, n. 5, p. 587, doi. 10.3390/bioengineering10050587
- By:
- Publication type:
- Article
Action potential metrics and automated data analysis pipeline for cardiotoxicity testing using optically mapped hiPSC-derived 3D cardiac microtissues.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0280406
- By:
- Publication type:
- Article
Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing.
- Published in:
- Altex, 2023, v. 40, n. 1, p. 103, doi. 10.14573/altex.2109131
- By:
- Publication type:
- Article
Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 01, doi. 10.3389/fcell.2024.1279932
- By:
- Publication type:
- Article
Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.
- Published in:
- Cellular & Molecular Bioengineering, 2021, v. 14, n. 5, p. 441, doi. 10.1007/s12195-021-00703-x
- By:
- Publication type:
- Article
In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment.
- Published in:
- Toxicological Sciences, 2024, v. 201, n. 1, p. 145, doi. 10.1093/toxsci/kfae079
- By:
- Publication type:
- Article